Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-18-060006

Chief Medical Officer acquired 149 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Levy Howard · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-11-26 Exercise or conversion : show line 1 in the form +149 $4.63 $690 7,709 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-11-26 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −149 $4.63 2027-07-11 149 87,118 D
Loading xslF345X03/doc4.xml…